View in EDS HTML Full Text PDF Full Text

Needle or Drip?—Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases.

Saved in:
Bibliographic Details
Title: Needle or Drip?—Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases.
Authors: Outtier, An1,2 (AUTHOR) An.outtier@uzleuven.be, Ferrante, Marc1,2 (AUTHOR) Marc.ferrante@uzleuven.be
Source: Digestive Diseases & Sciences. Jan2025, Vol. 70 Issue 1, p17-18. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 182469548
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Needle or Drip?—Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Outtier%2C+An%22">Outtier, An</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> An.outtier@uzleuven.be</i><br /><searchLink fieldCode="AR" term="%22Ferrante%2C+Marc%22">Ferrante, Marc</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> Marc.ferrante@uzleuven.be</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Digestive+Diseases+%26+Sciences%22">Digestive Diseases & Sciences</searchLink>. Jan2025, Vol. 70 Issue 1, p17-18. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=182469548
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10620-024-08772-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: 17
    Titles:
      – TitleFull: Needle or Drip?—Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Outtier, An
      – PersonEntity:
          Name:
            NameFull: Ferrante, Marc
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 01632116
          Numbering:
            – Type: volume
              Value: 70
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Digestive Diseases & Sciences
              Type: main
ResultId 1